Yuzhuang Li
Overview
Explore the profile of Yuzhuang Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
674
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Feng J, Pu Z, Li R, Li Y, Qin X, Zhang H, et al.
Virol Sin
. 2024 Jun;
39(4):699-701.
PMID: 38852919
No abstract available.
2.
Lin K, Xia B, Wang X, He X, Zhou M, Lin Y, et al.
J Transl Med
. 2024 Apr;
22(1):349.
PMID: 38610029
Background: Chimeric antigen receptor T (CAR-T) cell therapy, as an emerging anti-tumor treatment, has garnered extensive attention in the study of targeted therapy of multiple tumor-associated antigens in hepatocellular carcinoma...
3.
Xia B, Lin K, Wang X, Chen F, Zhou M, Li Y, et al.
Mol Ther Oncolytics
. 2023 Aug;
30:86-102.
PMID: 37593111
T cell lymphoma (TCL) is a highly heterogeneous group of diseases with a poor prognosis and low 5-year overall survival rate. The current therapeutic regimens have relatively low efficacy rates....
4.
Zhang Y, Li R, Li Y, Yang H, Zhou L, Yuan J, et al.
Signal Transduct Target Ther
. 2023 Jan;
8(1):25.
PMID: 36611028
No abstract available.
5.
Chen Y, Yan S, Pu Z, Feng J, Tan L, Li Y, et al.
Cancer Res
. 2022 Jul;
82(17):3130-3142.
PMID: 35802647
Significance: Identification of an immunostimulatory function of dopamine signaling by promoting tissue-resident memory T-cell differentiation and sustaining T-cell effector functions reveals potential therapeutic strategies and prognostic biomarkers for colorectal cancer.
6.
Chen R, Zhang X, Yuan Y, Deng X, Wu B, Xi Z, et al.
Adv Sci (Weinh)
. 2022 Feb;
9(11):e2105378.
PMID: 35142444
The SARS-CoV-2 Delta (B.1.617.2) strain is a variant of concern (VOC) that has become the dominant strain worldwide in 2021. Its transmission capacity is approximately twice that of the original...
7.
Yuan Y, Zhang X, Chen R, Li Y, Wu B, Li R, et al.
Cell Rep
. 2022 Jan;
38(3):110256.
PMID: 34990583
Inoculation against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is ongoing worldwide. However, the emergence of SARS-CoV-2 variants could cause immune evasion. We developed a bivalent nanoparticle vaccine that displays...
8.
Zhang X, Wu S, Wu B, Yang Q, Chen A, Li Y, et al.
Signal Transduct Target Ther
. 2021 Dec;
6(1):430.
PMID: 34921135
No abstract available.
9.
Peng Z, Zhang Y, Ma X, Zhou M, Wu S, Song Z, et al.
Front Immunol
. 2021 Sep;
12:728082.
PMID: 34512660
CD8 T cells are major components of adaptive immunity and confer robust protective cellular immunity, which requires adequate T-cell numbers, targeted migration, and efficient T-cell proliferation. Altered CD8 T-cell homeostasis...
10.
Zhang Y, Chen Y, Li Y, Huang F, Luo B, Yuan Y, et al.
Proc Natl Acad Sci U S A
. 2021 May;
118(23).
PMID: 34021074
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic and has claimed over 2 million lives worldwide. Although the genetic sequences of SARS-CoV and...